Emergent BioSolutions (EBS) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $2.00 +7.53%
Revenue Growth %: +12.3%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +12.3%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $192.5 million versus the consensus estimate of $199.47 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- BancFirst Corp. (BANF) Tops Q1 EPS by 11c
- Senesco Technologies, Inc. (SNT) Reports Q1 EPS of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
